Aberration in DNA Methylation in B-Cell Lymphomas Has a Complex Origin and Increases with Disease Severity

PLoS Genetics

Volumn 9, Issue 1, 2013, Pages

  De, Subhajyoti ^a,b   Shaknovich, Rita ^c   Riester, Markus ^d,e   Elemento, Olivier ^c   Geng, Huimin ^c   Kormaksson, Matthias ^c   Jiang, Yanwen ^c   Woolcock, Bruce ^f   Johnson, Nathalie ^f   Polo, Jose M ^g   Cerchietti, Leandro ^c   Gascoyne, Randy D ^f   Melnick, Ari ^c   Michor, Franziska ^d,e  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^g MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; GENOMIC DNA; TRANSCRIPTION FACTOR CTCF;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BINDING SITE; CHROMOSOME; DISEASE SEVERITY; DNA METHYLATION; EPIGENETICS; FOLLICULAR LYMPHOMA; GENE TARGETING; GENETIC ASSOCIATION; GERMINAL CENTER; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; LYMPHOCYTE SUBPOPULATION; NONHODGKIN LYMPHOMA; PROMOTER REGION; PROTEIN POLYMORPHISM;

B-LYMPHOCYTES; BINDING SITES; CELL LINE, TUMOR; DNA METHYLATION; EPIGENESIS, GENETIC; GENE SILENCING; GENOME, HUMAN; HUMANS; INSULATOR ELEMENTS; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS;

EID: 84873519286     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003137     Document Type: Article

References (44)

1. TNHLCP (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 89: 3909-3918.
2. Tan D, Horning SJ, (2008) Follicular lymphoma: clinical features and treatment. Hematol Oncol Clin North Am 22: 863-882, viii.
3. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, et al. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346: 1937-1947.
4. Klein U, Dalla-Favera R, (2008) Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 8: 22-33.
5. Shaknovich R, Cerchietti L, Tsikitas L, Kormaksson M, De S, et al. (2011) DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation. Blood 118: 3559-3569.
6. Shaknovich R, Geng H, Johnson NA, Tsikitas L, Cerchietti L, et al. (2010) DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma. Blood 116: e81-89.
7. Shaknovich R, Figueroa ME, Melnick A, (2010) HELP (HpaII tiny fragment enrichment by ligation-mediated PCR) assay for DNA methylation profiling of primary normal and malignant B lymphocytes. Methods Mol Biol 632: 191-201.
8. Figueroa ME, Skrabanek L, Li Y, Jiemjit A, Fandy TE, et al. (2009) MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation. Blood 114: 3448-3458.
9. Khulan B, Thompson RF, Ye K, Fazzari MJ, Suzuki M, et al. (2006) Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Res 16: 1046-1055.
10. Shaknovich R, Cerchietti L, Tsikitas L, Kormaksson M, De S, et al. (2011) DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation. Blood.
11. Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, et al. (2011) Increased methylation variation in epigenetic domains across cancer types. Nat Genet 43: 768-775.
12. Riester M, Stephan-Otto Attolini C, Downey RJ, Singer S, Michor F, (2010) A differentiation-based phylogeny of cancer subtypes. PLoS Comput Biol 6: e1000777 doi:10.1371/journal.pcbi.1000777.
13. TIN-HLPFP (1993) A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. New England Journal of Medicine 329: 987-994.
14. Uno H, Cai T, Pencina MJ, D'Agostino RB, Wei LJ, (2011) On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Statistics in Medicine 30: 1105-1116.
15. Turker MS, (2002) Gene silencing in mammalian cells and the spread of DNA methylation. Oncogene 21: 5388-5393.
16. Ahmed I, Sarazin A, Bowler C, Colot V, Quesneville H, (2011) Genome-wide evidence for local DNA methylation spreading from small RNA-targeted sequences in Arabidopsis. Nucleic Acids Res 39: 6919-6931.
17. Hathaway NA, Bell O, Hodges C, Miller EL, Neel DS, et al. (2012) Dynamics and memory of heterochromatin in living cells. Cell 149: 1447-1460.
18. Cuddapah S, Jothi R, Schones DE, Roh TY, Cui K, et al. (2009) Global analysis of the insulator binding protein CTCF in chromatin barrier regions reveals demarcation of active and repressive domains. Genome Res 19: 24-32.
19. Kim TH, Abdullaev ZK, Smith AD, Ching KA, Loukinov DI, et al. (2007) Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome. Cell 128: 1231-1245.
20. Ci W, Polo JM, Cerchietti L, Shaknovich R, Wang L, et al. (2009) The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL. Blood 113: 5536-5548.
21. Velichutina I, Shaknovich R, Geng H, Johnson NA, Gascoyne RD, et al. (2010) EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis. Blood 116: 5247-5255.
22. Yamane A, Resch W, Kuo N, Kuchen S, Li Z, et al. (2011) Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat Immunol 12: 62-69.
23. Skinnider BF, Horsman DE, Dupuis B, Gascoyne RD, (1999) Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities. Hum Pathol 30: 803-808.
24. Cattoretti G, Pasqualucci L, Ballon G, Tam W, Nandula SV, et al. (2005) Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell 7: 445-455.
25. van Galen JC, Dukers DF, Giroth C, Sewalt RG, Otte AP, et al. (2004) Distinct expression patterns of polycomb oncoproteins and their binding partners during the germinal center reaction. Eur J Immunol 34: 1870-1881.
26. Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, et al. (2010) Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 42: 181-185.
27. Suzuki J, Caputo GR, Kondo C, Higgins CB, (1990) Cine MR imaging of valvular heart disease: display and imaging parameters affect the size of the signal void caused by valvular regurgitation. AJR Am J Roentgenol 155: 723-727.
28. Rimsza LM, Leblanc ML, Unger JM, Miller TP, Grogan TM, et al. (2008) Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP. Blood 112: 3425-3433.
29. Xu Z, Pone EJ, Al-Qahtani A, Park SR, Zan H, et al. (2007) Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination. Crit Rev Immunol 27: 367-397.
30. Guo JU, Su Y, Zhong C, Ming GL, Song H, (2011) Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain. Cell 145: 423-434.
31. Bhutani N, Brady JJ, Damian M, Sacco A, Corbel SY, et al. (2010) Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 463: 1042-1047.
32. Weisenberger DJ, Velicescu M, Cheng JC, Gonzales FA, Liang G, et al. (2004) Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation. Mol Cancer Res 2: 62-72.
33. Angrand PO, Apiou F, Stewart AF, Dutrillaux B, Losson R, et al. (2001) NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines. Genomics 74: 79-88.
34. Morishita M, Di Luccio E, (2011) Cancers and the NSD family of histone lysine methyltransferases. Biochim Biophys Acta 1816: 158-163.
35. Kang D, Cho HS, Toyokawa G, Kogure M, Yamane Y, et al. (2012) The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis. Genes Chromosomes Cancer.
36. Attia M, Rachez C, De Pauw A, Avner P, Rogner UC, (2007) Nap1l2 promotes histone acetylation activity during neuronal differentiation. Mol Cell Biol 27: 6093-6102.
37. Leung GP, Lee L, Schmidt TI, Shirahige K, Kobor MS, (2011) Rtt107 is required for recruitment of the SMC5/6 complex to DNA double strand breaks. J Biol Chem 286: 26250-26257.
38. Roy MA, D'Amours D, (2011) DNA-binding properties of Smc6, a core component of the Smc5-6 DNA repair complex. Biochem Biophys Res Commun 416: 80-85.
39. Lai AY, Fatemi M, Dhasarathy A, Malone C, Sobol SE, et al. (2010) DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas. J Exp Med 207: 1939-1950.
40. Thompson RF, Reimers M, Khulan B, Gissot M, Richmond TA, et al. (2008) An analytical pipeline for genomic representations used for cytosine methylation studies. Bioinformatics 24: 1161-1167.
41. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, et al. (2011) The UCSC Genome Browser database: update 2011. Nucleic Acids Res 39: D876-882.
42. Flicek P, Amode MR, Barrell D, Beal K, Brent S, et al. (2011) Ensembl 2011. Nucleic Acids Res 39: D800-806.
43. Oberley MJ, Tsao J, Yau P, Farnham PJ, (2004) High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays. Methods Enzymol 376: 315-334.
44. Mukhopadhyay R, Yu W, Whitehead J, Xu J, Lezcano M, et al. (2004) The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide. Genome Res 14: 1594-1602.